COVID-19 vaccination in Singapore

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

COVID-19 vaccination in Singapore
Date30 December 2020 (2020-12-30) – present
LocationSingapore
CauseCOVID-19 pandemic in Singapore
Participants4,691,386 total doses administered[1][a]

COVID-19 vaccination in Singapore is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

Background[edit]

The Singapore Government invested more than one billion Singapore dollars to sign advanced purchase agreements and made early down payments on promising vaccine candidates, such as Pfizer BioNTech, Moderna and CoronaVac.[2]

On 14 December 2020, Singapore became the first Asian country to approve Pfizer-BioNTech's coronavirus vaccine.[3] The first shipment of the vaccine arrived on 21 December.[4][5]

Singapore also received its first shipment of China's Sinovac vaccine, on 22 December. However, the vaccine has yet to be authorised for use by the Health Sciences Authority (HSA).[6][7] On 2 June, MOH said Sinovac vaccine is approved for used in private healthcare settings where patients who are not eligible for mRNA vaccines can take the Sinovac vaccine, however, since the China-made vaccine is not part of the national programme, those who choose to receive it will not be eligible for the Vaccine Injury Financial Assistance Programme (VIFAP) should they develop any adverse reactions.[8]

On 30 December 2020, Singapore became the first country in Asia to start its COVID-19 vaccination campaign. The vaccine is free for all Singaporeans and long-term residents. Health workers, other frontline workers and seniors were the first inoculated with the vaccine jointly developed by BioNTech and Pfizer.[9]

On 3 February 2021, Singapore also became the first country in Asia to approve Moderna's COVID-19 vaccine, jointly developed by the National Institute of Allergy and Infectious Diseases (NIAID), the Biomedical Advanced Research and Development Authority (BARDA), and Moderna.[10]

On 18 May, the Health Ministry announced that those who register for COVID-19 vaccination from 19 May onwards will have their second dose scheduled six to eight weeks after the first, instead of three to four weeks later.[11] It was expected that Singapore would administer at least one dose of a coronavirus vaccine to its entire adult population by early August 2021.[12][13] In addition, the Health Sciences Authority (HSA) approved the use of the Pfizer-BioNTech coronavirus vaccine for children aged 12 to 15; previously, it was given only to those aged 16 years and above. It was granted interim authorization by the HSA under the Pandemic Special Access Route in December 2020.[13][14][15]

Vaccination programme[edit]

Total number of people who have received vaccinations in Singapore as of 14 June 2021

  Unvaccinated population: ~3.19 million people (54.21%)
  Population who have received only one dose of a two-dose vaccine: 709,506[16] (12.03%)
  Population who are fully vaccinated: 1,990,940[16] (33.76%)

Vaccines delivered per pharmaceutical company as of 22 June 2021 [refresh]

  Moderna (962,127) (23.77%)
  Pfizer-BioNTech (3,085,524) (76.23%)

Vaccines used[edit]

Vaccine Progress Doses ordered Approval Deployment Manufacturer Remarks
Pfizer–BioNTech Approved for use unknown Green check.svg 14 December 2020 (EUA) Green check.svg 30 December 2020 United StatesGermany Pfizer and BioNTech -
Moderna Approved for use unknown Green check.svg 3 February 2021 (EUA) Green check.svg 17 March 2021 United States Moderna -

Vaccine in Private Healthcare settings[edit]

Vaccine Progress Doses ordered Approval Deployment Manufacturer Remarks
CoronaVac Partially Approved 200,000 Yellow check.svg 2 June 2021 (EUA) Green check.svg 4 June 2021 China Sinovac -

Notes[edit]

  1. ^ 2,700,446 of these have only been administered with the first dose, while 1,990,940 have been fully vaccinated.

References[edit]

  1. ^ "COVID-19 Vaccination". www.moh.gov.sg. Retrieved 26 May 2021.
  2. ^ "Securing Singapore's access to COVID-19 vaccines". www.gov.sg. Retrieved 28 April 2021.
  3. ^ Daga, John Geddie, Anshuman (14 December 2020). "Singapore approves Pfizer's COVID-19 vaccine in Asia first". Reuters. Retrieved 28 April 2021.
  4. ^ "First shipment of COVID-19 vaccines arrives in Singapore". CNA. Retrieved 28 April 2021.
  5. ^ Limited, Bangkok Post Public Company. "Singapore gets first batch of vaccines, says DHL". Bangkok Post. Retrieved 28 April 2021.
  6. ^ "Sinovac vaccine will be used only when HSA gives approval". The New Paper. 25 March 2021. Retrieved 28 April 2021.
  7. ^ "China's Sinovac vaccine arrives in Singapore, but not yet approved for use". www.businesstimes.com.sg. Retrieved 28 April 2021.
  8. ^ "Sinovac vaccine will be given to individuals not eligible for MRNA vaccines". The Straits Times. 2 June 2021. Retrieved 2 June 2021.
  9. ^ "Singapore begins COVID-19 vaccination campaign". www.aa.com.tr. Retrieved 28 April 2021.
  10. ^ Staff, Reuters (3 February 2021). "Singapore approves Moderna's COVID-19 vaccine in Asia first". Reuters. Retrieved 28 April 2021.
  11. ^ hermesauto (18 May 2021). "S'pore delays 2nd Covid-19 vaccine dose to 6-8 weeks later; those aged 40-44 can register for jabs from Wednesday". The Straits Times. Retrieved 21 May 2021.
  12. ^ "Singapore seeks COVID-19 vaccination for all adults by August". news.yahoo.com. Retrieved 21 May 2021.
  13. ^ a b "COVID: Singapore vaccination extended to 12-15 age group, dosing interval now 6-8 weeks". news.yahoo.com. Retrieved 21 May 2021.
  14. ^ Ng, Abigail (18 May 2021). "Singapore approves Covid vaccine for children ages 12 to 15 as cases surge". CNBC. Retrieved 21 May 2021.
  15. ^ "Children aged 12 to 15 to receive Pfizer-BioNTech COVID-19 vaccine in Singapore". CNA. Retrieved 21 May 2021.
  16. ^ a b MOH (14 June 2021). "COVID Data Tracker". Ministry of Health(Singapore). Retrieved 14 June 2021.